(17314293), C. R., (21632380), A. O., (21632383), C. M., (15331351), R. B., (21468025), D. J., (16494599), C. S., . . . (15055771), P. K. P. (2025). Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib.

(17314293), Christian Rolfo, Aurora O’Brate (21632380), Christoph Menzel (21632383), Rolf Bruns (15331351), Dilafruz Juraeva (21468025), Christopher Stroh (16494599), Andreas Johne (15331354), and Paul K. Paik (15055771). Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib. 2025.

(17314293), Christian Rolfo, et al. Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib. 2025.